Amicus Therapeutics
FOLD
FOLD
95 hedge funds and large institutions have $280M invested in Amicus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
58% more funds holding
Funds holding: 60 → 95 (+35)
13% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 16
Holders
95
Holding in Top 10
3
Calls
$4.08M
Puts
$2.41M
Top Buyers
1 | +$11.1M | |
2 | +$7.43M | |
3 | +$7.33M | |
4 |
Millennium Management
New York
|
+$6.94M |
5 |
D.E. Shaw & Co
New York
|
+$5.48M |
Top Sellers
1 | -$12M | |
2 | -$11.6M | |
3 | -$2.39M | |
4 |
UBS AM
Chicago,
Illinois
|
-$2.3M |
5 |
GTC
Ghost Tree Capital
New York
|
-$2M |